Nerve-Stimulating Device for Cancer Wasting Enters First Human Trial
OnVagus has received approval to begin the first human trial of its noninvasive vagus nerve-stimulation device for cancer-related wasting at ...
OnVagus has received approval to begin the first human trial of its noninvasive vagus nerve-stimulation device for cancer-related wasting at ...
The Terasaki Institute for Biomedical Innovation will lead a multi-institution effort, backed by up to $19.8 million from ARPA-H's PRINT ...
The Terasaki Institute for Biomedical Innovation (TIBI) and the California Institute of Technology (Caltech) have joined forces in a groundbreaking ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine